Literature DB >> 18380631

Estimating the cost of complications of diabetes in Australia using administrative health-care data.

Philip Clarke1, Jose Leal, Chris Kelman, Merran Smith, Stephen Colagiuri.   

Abstract

OBJECTIVES: To estimate Australian health-care costs in the year of first occurrence and subsequent years for major diabetes-related complications using administrative health-care data.
METHODS: The costs were estimated using administrative information on hospital services and primary health-care services financed through Australia's national health insurance system Medicare. Data were available for 70,340 patients with diabetes in Western Australia (mean duration of 4.5 years of follow-up). Multiple regression analysis was used to estimate inpatient and primary care costs.
RESULTS: For a man aged 60 years, the average costs in the year the event first occurred were: amputation $20,416 (95% CI 18,670-22,411); nonfatal myocardial infarction (MI) $11,660 (10,931-12,450); nonfatal stroke $14,012 (12,849-15,183); ischaemic heart disease $12,577 (12,026-13,123); heart failure $15,530 (13,965-17,009); renal failure $28,661 (22,989-34,202); and chronic leg ulcer $15,413 (13,089-18,123). The costs in subsequent years for a man aged 60 years range from 14% for nonfatal MI to 106% for renal failure, of event costs.
CONCLUSIONS: Estimates of the health-care costs associated with diabetes-related complications can be used in modeling the long-term costs of diabetes and in evaluating the cost-effectiveness of improving care.

Entities:  

Mesh:

Year:  2008        PMID: 18380631     DOI: 10.1111/j.1524-4733.2007.00228.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  24 in total

Review 1.  Improved wound management at lower cost: a sensible goal for Australia.

Authors:  Rosana E Norman; Michelle Gibb; Anthony Dyer; Jennifer Prentice; Stephen Yelland; Qinglu Cheng; Peter A Lazzarini; Keryln Carville; Karen Innes-Walker; Kathleen Finlayson; Helen Edwards; Edward Burn; Nicholas Graves
Journal:  Int Wound J       Date:  2015-12-03       Impact factor: 3.315

2.  Cost-effectiveness of an electronic medical record based clinical decision support system.

Authors:  Todd P Gilmer; Patrick J O'Connor; JoAnn M Sperl-Hillen; William A Rush; Paul E Johnson; Gerald H Amundson; Stephen E Asche; Heidi L Ekstrom
Journal:  Health Serv Res       Date:  2012-05-11       Impact factor: 3.402

3.  Chronic wounds in Australia: A systematic review of key epidemiological and clinical parameters.

Authors:  Laura McCosker; Ruth Tulleners; Qinglu Cheng; Stefan Rohmer; Tamzin Pacella; Nick Graves; Rosana Pacella
Journal:  Int Wound J       Date:  2018-09-26       Impact factor: 3.315

4.  A cost-effectiveness analysis of optimal care for diabetic foot ulcers in Australia.

Authors:  Qinglu Cheng; Peter A Lazzarini; Michelle Gibb; Patrick H Derhy; Ewan M Kinnear; Edward Burn; Nicholas Graves; Rosana E Norman
Journal:  Int Wound J       Date:  2016-08-04       Impact factor: 3.315

5.  The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in Japan.

Authors:  Haruhisa Fukuda; Shunya Ikeda; Takeru Shiroiwa; Takashi Fukuda
Journal:  Pharmacoeconomics       Date:  2016-10       Impact factor: 4.981

6.  Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitus.

Authors:  Hillary R Bogner; Steven D Miller; Heather F de Vries; Sumedha Chhatre; Ravishankar Jayadevappa
Journal:  J Card Fail       Date:  2010-03-06       Impact factor: 5.712

7.  Quality of diabetes follow-up care and hospital admissions.

Authors:  L F Andrade; T Rapp; C Sevilla-Dedieu
Journal:  Int J Health Econ Manag       Date:  2018-06

8.  Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data.

Authors:  Ulf-G Gerdtham; Philip Clarke; Alison Hayes; Soffia Gudbjornsdottir
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

9.  Simulating lifetime outcomes associated with complications for people with type 1 diabetes.

Authors:  Tom W C Lung; Philip M Clarke; Alison J Hayes; Richard J Stevens; Andrew Farmer
Journal:  Pharmacoeconomics       Date:  2013-06       Impact factor: 4.981

10.  Exploring the determinants of endocrinologist visits by patients with diabetes.

Authors:  Luiz Flavio Andrade; Thomas Rapp; Christine Sevilla-Dedieu
Journal:  Eur J Health Econ       Date:  2016-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.